Clinical Trial Update: A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ALL. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating olverembatinib in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia, with patient recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Olverembatinib (Olverembatinib)

Snippet

Sponsor: Ascentage Pharma Group Inc. | Conditions: Ph+ ALL | Phase 3 | Status: RECRUITING